Thursday, October 10, 2019

NATURE AND WORLD

NEW YORK (Reuters) - Vir Biotechnology priced its initial public offering (IPO) at $20 a share on Thursday, at the bottom end of expectations,...

from U.S. News - Civic https://ift.tt/2MzusiZ
Share:

0 comments:

Post a Comment

Translate

ABOUT

THIS BLOG DISPLAYS ONLINE IMPORTANT NEWS OF USA.

Unordered List

Support